DARPA gives $6M+ grant for PTSD neurostim; Philips to buy emergency dept. consultancy;

@FierceMedDev: Cancer Genetics makes strides in $14M deal for Response Genetics. FierceDiagnostics article | Follow @FierceMedDev

@EmilyWFierce: ICYMI: Want to get a warning letter from OPDP? Omit drug risks from your promos. More from FiercePharmaMarketing | Follow @EmilyWFierce

> Researchers at the Texas Biomedical Device Center at the University of Texas at Dallas got a four-year Defense Advanced Research Projects Agency (DARPA) grant for up to $6.4 million to research vagus nerve stimulation to reduce the fear response in post-traumatic stress disorder (PTSD) patients. More

> Royal Philips ($PHG) will acquire U.S. hospital emergency department consultancy Blue Jay Consulting as part of its ongoing refocus on to HealthTech. Financial details remained undisclosed. More

> The Office for Civil Rights under the U.S. Department of Health and Human Services has launched a site advising companies developing apps that are intended to be HIPAA-compliant. Site

Biotech News

@FierceBiotech: After a $191M IPO, Adaptimmune buys a new cancer R&D outpost. More | Follow @FierceBiotech

@JohnCFierce: Sold out the Fierce London biotech conference, which is cool. Thank you, UK. Event | Follow @JohnCFierce

@DamianFierce: Yes, good fun, my hip-hop peers, but what's REALLY wack is chronic obstructive pulmonary disease. | Follow @DamianFierce

> Take the poll: Has the biotech boom come to an end? Poll

> Axovant rolls into Phase III with a risky Alzheimer's gambit. More

Pharma News

@FiercePharma: Something's got to give in India's pharma policy contradictions. More | Follow @FiercePharma

@EricPFierce: AmerisourceBergen injects itself into compounding industry with $2.5B deal for PharMEDium. Article | Follow @EricPFierce

@CarlyHFierce: Payers want new guidelines, more data before easing access to diabetes' CV star Jardiance. Story | Follow @CarlyHFierce

> Drug price hikes a tried-and-true strategy for who's who of Big Pharma. More

> Roche CEO: Big Data needs Big Pharma, and vice versa. News

Drug Delivery News

> Perrigo licenses Flamel's oral suspension delivery platform to develop additional OTC meds. More

> Novel catheter designed for rectal drug delivery wins CE mark. Article

> GSK obtains rights to inhaled nanoparticles made using Liquidia's PRINT platform. News

> Genisphere snags $4M to move its 3DNA platform into the clinic. Story

> Polymer microneedles embedded with cancer drugs degrade to treat skin carcinomas. More

Pharma Manufacturing News

> AmerisourceBergen lays out $2.5B for sterile compounder PharMEDium. Article

> Baxter recalls more saline, this time for potential mold contamination. Report

> India intends to establish drug testing labs in effort to boost quality. Item

> Hospira recalls more lidocaine with rust embedded in vials. Story

> Pfizer adding jobs to Ireland plant that had been slated to close. Article

Pharma Asia News

> JHL Biotech tests the waters on Taiwan's Emerging Stock Board. Item

> Something's got to give in India's pharma policy contradictions. More

> India considers drug testing labs in each state. Report

> TPP negotiators said to reach compromise on biologics. Story

> Japanese flu vaccine makers pump up prices 50%, drawing flak as peak season hits. Article

Suggested Articles

BD will begin offering a point-of-care COVID-19 antibody assay, which operates like a combination of a blood glucose test and a home pregnancy test.

Smith+Nephew is contracting with the U.K. government to build a new ventilator specifically designed for large-scale production.

NantWorks’ ImmunityBio has begun a supercomputing collaboration with Microsoft to map out the spike protein of the novel coronavirus.